Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Takeshi Kimura

Takeshi Kimura

Ajinomoto Co. Inc., Japan

Jaleel Kareem Ahmed

Jaleel Kareem Ahmed

University of Babylon Iraq

A Vieira

A Vieira

Simon Fraser University, Canada

Joseph Fomusi Ndisang

Joseph Fomusi Ndisang

University of Saskatchewan College of Medicine Canada

Kevin Contrepois

Kevin Contrepois

Michael Snyder laboratory USA

Nadia Mudher Sulaiman

Nadia Mudher Sulaiman

Babylon University Iraq

Petras Dzeja

Petras Dzeja

Mayo Clinic USA

Ramon Cacabelos

Ramon Cacabelos

EuroEspes Biomedical Research Center Spain

Metabolomics Congress 2019

About Metabolomics Congress 2019

Conference Series llc LTD  invites you to the 15th International Conference and Exhibition on Metabolomics & Systems Biology during April 29-30,2019,Kyoto Japan. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.

Metabolomics Congress 2019 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more.

Conference is attracting academicians including Professors,PhD Scholars, Students ,Pharmaceutical Industrial Giants, Toxicology Societies and the people Associated, Nobel laureates in Health Care and Medicine, Life science experts, Pharmaceutical companies, Clinical Laboratories and Technicians , Bioinformatics Professionals, Research Institutes and members,Supply Chain companies, Manufacturing Companies, Training Institutes, Business Entrepreneurs.


Biochemistry Conferences 2019  is delighted to welcome each one of the individuals to the "Metabolomics congress 2019" amidst April 29 - April 30, 2019 at Kyoto, Japan which provide a forum for exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field.

Metabolomics congress 2019 will be underlined by the presence of academicians including metabolomics educators,postgraduates,affiliations,Industrial Giants ,Business Entrepreneurs etc.This meeting comprise brief Keynote presentations, Speaker talks, Exhibition, Symposia and Workshops.


Conference will be the  perfect platform for:

Laudable scientific talks by global scientific community

Sterling workshop sessions

Awards and Global Recognition to meritorious Researchers

Global Networking opportunities with 50+ Countries

Novel Techniques to Benefit Your Research

Exquisite Platform for showcasing your products and International Sponsorship


Theme: Metabolomics:Recent trends and future challenges

Track 1 : Cancer Therapeutic Approaches 

Cancer biomarkers have many potential applications in cancer treatment, including screening,diagnosis, risk assessment, prediction of response to treatment, and monitoring of progression of disease. Metabolomics is growing in the field with particular attention to its application as a biomarker in cancer diagnosis.Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, lipids, nucleic acids, proteins, sugars, and little metabolites, cytokinetic and cytogenetic parameters etc.

Track 2 : Metabolic Syndrome

Metabolic syndrome in short words can be explained as a group of conditions which includes increased blood pressure, abnormal cholesterol, high blood sugar, excess body fat around the waist, and or triglyceride levels — that occur together, increasing your risk of heart disease, diabetes and stroke. It is closely related to inactivity and overweight. Recent researches proved that prolonged chronic stress can be a cause for metabolic syndrome by disrupting the hormonal balance of the hypothalamic-pituitary-adrenal axis.

.Track 3 : Metabolomics in Precision Medicine

Precision medicine is rapidly developing tool for medical treatment to a small group or even individual patients based on their genetics,lifestyle and environment. It relies heavily on developments in systems biology and omics disciplines, including metabolomics. While a few advances in prescription have been made, the practice is not as of now being used for most diseases.

Track 4 : Frontiers of Metabolomics Research

Metabolomic studies can incite enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower  use of computational approaches to manage the examination of disease and biomedical frames. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to enhance a more extensive cluster of little particle metabolites.

Track 5 : Therapeutic Metabolomics

Metabolites has non-invading nature and close relation to the phenotype .That make it a perfect tool for the pharmaceutical, agricultural industries and preventive healthcare among others. Therapeutic metabolomics studies are done by Centre for Metabolomics.Computational immunology is the branch of science that incorporates bioinformatics ways and high-throughput genomic to deal with immunology.

Track 6 : Transcriptomics & Metabolic pathways

Transcriptomic studies deals with the measurement of simultaneous expression of up to thousands of genes and can be used to identify which genes are down or up regulated under certain conditions. Metabolic pathway is a series of concoction responses occuring inside a cell. In a pathway metabolite,the beginning compound is changed by an arrangement of synthetic responses. These responses are catalyzed by enzymes.These chemicals frequently require dietary minerals, vitamins, and different cofactors to work.Metabolic pathways are classified as anabolic and catabolic pathways.

Track 7 : Metabolic Modelling

Metabolic modelling is done to have a deep insight into the molecular mechanisms of a particular organism. The metabolic pathways breaks down into their respective reactions and enzymes through reconstruction process and analyses them within the perspective of the entire network.A mathematical model is created by collecting all the relevant metabolic information of the organism. A deep analysis of these reconstructed pathways can allow identification of key features of metabolism such as robustness,gene essentiality,growth yield and resource distributionThis information can then be applied to create novel biotechnological methods.

Track 8 : Clinical Metabolomics & Lipidomics

Clinical metabolomics involves the application of clinical laboratory protocols ,standards and oversight to a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways.Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.

Track 9 : Plant & Environmental Metabolomics

Metabolomics is the study of exogenous and endogenous low atomic mass metabolites inside of a cell, tissue, or bio fluid of a life form. Plant Metabolomics deals with evaluation of plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool of plants under particular conditions where as environmental metabolomics is the utilization of strategies to find out the relation between life forms with their surroundings Using Metabolomics, a better understanding of the correlation between biochemical composition and genes of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function

Track 10 : Food & Nutritional Metabolomics

Nutritional metabolomics is use chemical profiling of small molecule to support assimilation of nutrition and diet in complex biosystems research.Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics derived from the digestion and biotransformation of foods and their constituents in which MS techniques are considered indispensable.

Track 11: Metabolomic devices

Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex. Bruker, AB SCIEX, and Thermo Fisher likewise offer instruments for imaging MS, additionally called MALDI imaging.

Track 12 : Analytical Platforms in Metabolomics

Metabolomics is the subjective and quantitative investigation of small particles such as thiols, lipids, amino acids, nucleic acids, vitamins,peptides, natural acids and starches etc. The current advancement of diagnostic stages such as UPLC,GC, HPLC,CE coupled to MS and NMR spectroscopy  empowers measurement, partition ,portrayal,discovery and of these metabolites and other related metabolic pathways.

Track 13 : Data Analysis & Systems Biology

Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.

Track 14 : Enhancing Analytical Approaches

The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy  has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Aglient Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.

Track 15 : Case Reports 

Metabolites are key regulators of systems homeostasis. As such, changes in concentrations and fluxes of specific groups of metabolites may reflect systemic responses to environmental, lifestyle, and therapeutic challenges. Thus, case reports are inevitable factors in metabolite studies.Different case studies includes heart disease,clinical studies,diabetes studies,cancer cases etc.

Related Socities and Associations :

Metabolomics Society,American association for the advancement of science,American association for clinical chemistry  ,American association for cancer research,American association of pharmaceutical scientists,Association for Consumer Research (ACR),American cancer society,Bioinformatics society of India,Nutrigenomics Organization.The British Society for Genetic Medicine,The Genetics Society,Netherlands metabolomics center,The Australian biotechnology association,Human Proteome Organization,Indiana Proteomics Consortium,Proteome Society,European federation of biotechnology,Australasian Proteomics Society,Clinical Genetics Society

Market Analysis


Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more.  Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.

'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.

Importance & Scope:

Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.

The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Centre for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Why Kyoto, Japan  ?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor , the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013 . By 2018, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for metabolomics companies, as a high amount of metabolomics research is being conducted in the country.


                                            Global Life science Market Share by Country

Why to attend ???

Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Metabolomics Related Associations around the Globe :

Metabolomics Society
American association for the advancement of science
American association for clinical chemistry  
American association for cancer research
American association of pharmaceutical scientists
Association for Consumer Research (ACR)
American cancer society
Bioinformatics society of India
Nutrigenomics Organization
The British Society for Genetic Medicine
The Genetics Society
Netherlands metabolomics center
The Australian biotechnology association
Human Proteome Organization
Indiana Proteomics Consortium
Proteome Society
European federation of biotechnology
Australasian Proteomics Society
Clinical Genetics Society

Major Metabolomics Related  Research Units in Japan :

RIKEN Center for Sustainable Resource Science
Institute for Advanced Biosciences, Keio University
Human Metabolome Technologies
Osaka University
University of Tokyo
Kyoto University
University of Tsukuba
Nagoya University
Hokkaido University
University of Tsukuba

Target Audience: 

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.  

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market. 

Glance at Market of Metabolomics:

The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. 

Statistics which shows growth in importance of Metabolomics :

Metabolomics Market Worth $2,100 Million by 2019 - New Report by  Markets and Markets.

Statistics of Industries Associated with Metabolomics :

North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.). 

Fund Allotment towards Metabolomics Research :

The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida. 

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.

NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.

  • Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) 
  • NIH    West Coast Metabolomics Center at UC Davis
  • Southeast Center for Integrated Metabolomics (SECIM) 
  • Metabolomics Core at Mayo Clinic 
  • Research Center for Stable Isotope Resolved Metabolomics

Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.

Metabolomic Diagnostics is engaged in a study called IMPROvED, which has received  €6m in European FP7 funding. 

Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years. 

Past Conference Report

Metabolomics Congress 2018

The 11th International Conference and Exhibition on Metabolomics & Systems Biology, Metabolomics Congress 2018 was held in Tokyo, Japan during May 17-19, 2018.

Metabolomics Congress 2018 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC ltd was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas.  

The conference aimed a parallel rail with theme “Metabolomics: From Fundamentals to Clinical Applications”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the chair members Dr.Kevin Contrepois from Michael Snyder laboratory,USA and Dr.Joseph Fomusi Ndisang, University of Saskatchewan College of Medicine,Canada for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Jaleel Kareem Ahmed, University of Babylon, Iraq; Takeshi Kimura, Ajinomoto Co.,Inc, Japan; A.Vieira, Simon Fraser University, Canada; Kevin Contrepois from Michael Snyder laboratory,USA; Joseph Fomusi Ndisang, University of Saskatchewan College of Medicine,Canada; Nadia Mudher Sulaiman from University of Babylon, Iraq; Sergey Gorianov, from RUDN,Russian Federation; Anuri Shah from King’s College London, UK; Ya-Ju Hsieh from Molecular medicine Research center, Taiwan; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC ltd is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC ltd  offers its heartfelt appreciation to all the media partners for the promotion of our event to glory.

Conference Series LLC ltd  on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC ltd  11th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.

After the successful completion of 13 consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in Japan is

“15th International Conference and Exhibition on Metabolomics and Systems Biology” which is going to be held during April 29-30, 2019 in Kyoto,Japan.

Mark your calendars; we are hoping to see you soon!

Let us meet again @ Metabolomics Congress 2019


Past Reports  Gallery  

Metabolomics Congress 2017

Past Reports  Gallery  

Metabolomics Congress 2016

Past Reports  Gallery  


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 29-30,2019

Speaker Opportunity

Supported By

Journal of Metabolomics:Open Access Journal of Computer Science & Systems Biology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner